Recent studies have also shown that PKC activators induce PKC-dependent export of ZKSCAN3 from the nucleus and also promote clearance of amyloid β (Aβ) plaques in mouse models of Alzheimer’s disease [17]. This evidence concerns the gene PRRT2 and early-onset autosomal dominant Alzheimer disease.